Lazertinib 240mg tablets
- SNOMED code
45010711000001102- Active compound
- Lazertinib
- Preferred name basis
- rINN - Recommended International Non-proprietary
- Prescribable
- ✅ Yes
- Dose form
- Discrete
- Dose size and units
- 1 tablet, tablet
- Ingredients
- Lazertinib mesilate monohydrate, ID: 44992511000001106
— 240 mg
based on base substance
- Form & Route
- tablet.oral
Oral tablet, Oral - Controlled drug
- No Controlled Drug Status
Products
Lazcluze 240mg tablets (Janssen-Cilag Ltd)
Lazcluze 240mg tablets
- SNOMED code
44990311000001104- Supplier
- Janssen-Cilag Ltd
- Licensed as
- Medicines - MHRA/EMA
- EMA (European Medicines Agency) Monitoring
- ▼ Yes, black triangle marked
- Availability restrictions
- None
- Licensed route
- Oral
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Lazcluze 240mg tablets (Janssen-Cilag Ltd) 28 tablet 2 x 14 tablets44990411000001106 ref. pack | 💯 Available Legal category: POM | 501267490439805012674904398 | NHS Indicative Price £6,192 | • Hospital |
| — |
Reference packs
Lazertinib 240mg tablets 28 tablet
- SNOMED code
44990211000001107- Quantity and unit
- 28 tablet
- Packs